Novartis Home

At Novartis, we are reimagining medicine
At Novartis, we are reimagining medicine
Navigate Novartis
Call for renewed drive against malaria
Our Renewed Commitment to Fighting Malaria
-
850M
Antimalarial treatments provided without profit since 2001
-
USD 100M
Investment to advance R&D of next-generation antimalarials up to 2023
Leadership Perspective
"Resistance to treatment presents the biggest threat to the incredible progress that has been made in the fight against malaria in the past 20 years. We cannot afford to wait; this is why we are committing to advance the research and development of next-generation treatments. At the same time, we need to work to ensure that our innovation reaches those most in need, even those in the most remote locations."
Malaria Initiative Stories